Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $24.7200 (-9.28%) ($24.7200 - $24.7200) on Thu. Nov. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4% (three month average) | RSI | 33 | Latest Price | $24.7200(-9.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -5.8% a day on average for past five trading days. | Weekly Trend | TGTX declines -8.9% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(70%) ARKG(66%) IBB(63%) ARKK(61%) IWO(60%) | Factors Impacting TGTX price | TGTX will decline at least -2% in a week (0% probabilities). VIXM(-49%) VXX(-40%) UUP(-20%) UNG(-6%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2% (StdDev 4%) | Hourly BBV | -2.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $12.27(-50.36%) | Resistance Level | $31.46 | 5 Day Moving Average | $27.43(-9.88%) | 10 Day Moving Average | $30.62(-19.27%) | 20 Day Moving Average | $31.46(-21.42%) | To recent high | -30.5% | To recent low | 14% | Market Cap | $3.131b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |